0NHS Stock Chart & Stats
$69.73
-$0.32(-0.46%)
At close: 4:00 PM EDT
$69.73
-$0.32(-0.46%)
Day’s Range― - ―
52-Week Range$53.05 - $87.36
Previous CloseN/A
Volume568.00
Average Volume (3M)3.64K
Market Cap
$33.10B
Enterprise Value$69.01K
Total Cash (Recent Filing)$777.55M
Total Debt (Recent Filing)$13.96B
Price to Earnings (P/E)14.0
Beta0.66
Next Earnings
Nov 04, 2026EPS Estimate
1.16Next Dividend Ex-DateN/A
Dividend Yield3.14%
Share Statistics
EPS (TTM)4.92
Shares Outstanding480,023,560
10 Day Avg. Volume2,398
30 Day Avg. Volume3,636
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)1.19
Price to Sales (P/S)1.12
P/FCF Ratio14.73
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$78.40Price Target Upside12.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
EPS Forecast (FY)5.52
Revenue Forecast (FY)$28.02B
Bulls Say, Bears Say
Bulls Say
Integrated Business ModelNutrien's integration of upstream fertilizer manufacturing with a broad retail footprint creates durable demand visibility and margin capture across the value chain. The retail network smooths seasonality, supports recurring service revenue and cross‑sells proprietary products, strengthening cash generation through cycles.
Margin Recovery And Stabilized RevenuesMargins and top‑line have meaningfully rebounded from 2023–2024 lows, showing improved operating leverage and pricing realization. Sustained mid‑cycle margins near current levels would support consistent free cash flow and bolster reinvestment, buybacks and balance sheet repair even in a volatile commodity environment.
Strong Operational Execution And VolumesRecord upstream shipments, high nitrogen plant utilization and improved upstream volumes reflect operational reliability and execution. Higher realized volumes and plant efficiency sustain earnings power, reduce controllable cash costs, and improve resilience to cyclical price swings over the medium term.
Bears Say
Phosphate Margin PressureElevated sulfur and ammonia input costs have eroded phosphate profitability despite volume recovery, implying structural margin vulnerability if input inflation persists. Continued cost exposure and limited pass‑through could constrain segment cash generation and force strategic actions that depress near‑term returns.
Geopolitical Supply DisruptionMaterial trade disruptions tied to Middle East routes increase volatility in feedstock and export flows, raising freight, insurance and input costs. Persistent disruption can lift global benchmarks and input inflation, tightening margins across upstream and retail channels and reducing predictability of volumes and cash flows.
Asset And Portfolio UncertaintyAsset sales and strategic reviews (Trinidad, parts of Brazil, phosphate) signal structural challenges and potential one‑off charges or lower future earnings from divestments. Operational shutdowns reduce supply flexibility and create execution risk; portfolio reshaping can be value‑creative but adds near‑term uncertainty to cash flows and margins.
Nutrien News
0NHS FAQ
What was Nutrien Ltd’s price range in the past 12 months?
Nutrien Ltd lowest share price was $53.05 and its highest was $87.36 in the past 12 months.
What is Nutrien Ltd’s market cap?
Nutrien Ltd’s market cap is $33.10B.
When is Nutrien Ltd’s upcoming earnings report date?
Nutrien Ltd’s upcoming earnings report date is Nov 04, 2026 which is in 90 days.
How were Nutrien Ltd’s earnings last quarter?
Nutrien Ltd released its earnings results on Aug 05, 2026. The company reported $2.612 earnings per share for the quarter, missing the consensus estimate of $2.72 by -$0.108.
Is Nutrien Ltd overvalued?
According to Wall Street analysts Nutrien Ltd’s price is currently Undervalued.
Does Nutrien Ltd pay dividends?
Nutrien Ltd pays a Quarterly dividend of $0.55 which represents an annual dividend yield of 3.14%. See more information on Nutrien Ltd dividends here
What is Nutrien Ltd’s EPS estimate?
Nutrien Ltd’s EPS estimate is 1.16.
How many shares outstanding does Nutrien Ltd have?
Nutrien Ltd has 480,023,560 shares outstanding.
What happened to Nutrien Ltd’s price movement after its last earnings report?
Nutrien Ltd reported an EPS of $2.612 in its last earnings report, missing expectations of $2.72. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Nutrien Ltd?
Currently, no hedge funds are holding shares in GB:0NHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nutrien Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$78.40 (12.43% Upside)
$78.40 (12.43% Upside)
Blogger Sentiment
Neutral
GB:0NHS Sentiment 50%
Sector Average 68%
Sector Average 68%
Insider Transactions
Bought Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.89%
12-Months-Change
Fundamentals
Return on Equity
3.14%
Trailing 12-Months
Asset Growth
1.61%
Trailing 12-Months
Company Description
Nutrien Ltd
Nutrien Ltd. is a prominent agricultural company dedicated to supplying crucial crop inputs and comprehensive services to the farming sector. It specializes in the production and provision of essential plant nutrients like potash, nitrogen, phosphate, and sulfate, alongside offering financial support to its clientele. The company leverages an expansive retail footprint of roughly 2,000 locations across the United States, Canada, South America, and Australia to distribute a full spectrum of agricultural products, including fertilizers, crop protection solutions, seeds, and various merchandise. Furthermore, Nutrien directly assists growers through a network of farm centers strategically placed throughout North America, South America, and Australia. The company, established in 2017, maintains its corporate headquarters in Saskatoon, Canada.
0NHS Company Deck
0NHS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong operational execution and several clear financial successes in Q1 — notably $1.1 billion adjusted EBITDA, record potash shipments, solid nitrogen performance (92% ammonia operating rate), maintained guidance ranges, ongoing buybacks, and cost-discipline actions. However, material macro and operational risks remain: the Middle East conflict has already disrupted >30% of urea trade and ~25% of ammonia/phosphate trade, driving higher input costs (sulfur, ammonia, gas), pressuring phosphate margins (Q1 phosphate EBITDA only $57M despite +20% production), and leaving specific assets (Trinidad, parts of Brazil) under strategic review or shut down. On balance, management preserved guidance, demonstrated flexibility in operations and capital allocation, and delivered meaningful quarter-over-quarter improvements, but acknowledged notable commodity, geopolitical and portfolio risks that could weigh on results if prolonged.View all GB:0NHS earnings summaries0NHS Stock 12 Month Forecast
Average Price Target
$78.40
▲(12.43% Upside)
Technical Analysis
Bee Vectoring Technologies International
―
Karnalyte Resources
―
Verde Agritech
―
Itafos
―
MustGrow Biologics
―